Effectiveness And Safety Of Apixaban, Dabigatran And Rivaroxaban Versus Warfarin In Obese Patients With Nonvalvular Atrial Fibrillation: Aristophanes Subgroup Analysis

Steven Deitelzweig,Allison Keshishian,Amiee Kang,Amol Dhamane,Xuemei Luo,Xiaoyan Li,Neeraja Balachander,Lisa Rosenblatt,Jack Mardekian,Xianying Pan,Manuela Di Fusco, Alessandra Bassalobre Garcia,Huseyin Yuce,Gregory Y.H. Lip

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2019）

引用 2|浏览14

暂无评分

摘要

The prevalence of obesity in nonvalvular atrial fibrillation (NVAF) patients is apparent in trials and real-world studies; however, there is limited data on the effectiveness and safety of anticoagulation specific to this population. This study evaluated stroke/systemic embolism (SE) and major

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要